BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 15, 2011
View Archived Issues
ArQule and Daiichi Sankyo disclose preclinical findings on ARQ-092
Read More
New biomarker for dengue fever identified
Read More
Acasti Pharma begins second phase II CaPre study
Read More
New serine/threonine-protein kinase ATR inhibitors claimed
Read More
Second remissions evaluated in epratuzumab study in relapsed acute lymphoblastic leukemia
Read More
Paladin Labs launches product for digoxin toxicity and overdose in Canada
Read More
New glimepiride formulation launched in Japan
Read More
Neoprobe licenses imaging agent from AstraZeneca
Read More
Antitumor effects of K-560 evaluated in preclinical settings
Read More
Novel antimalarial is potent without inducing parasite dormancy
Read More
Researchers at Chemilia design new anticancer agents
Read More
New histamine H3 receptor modulators presented
Read More
Novel antibacterial and antifungal agents disclosed by A*STAR
Read More
Baxter International signs acquisition agreement
Read More
Tarsa Therapeutics plans NDA submission for oral recombinant calcitonin
Read More
FDA committee issues vote on Adasuve
Read More
Japanese phase II/III trial in osteoporosis meets primary endpoint
Read More
Simcere and Bristol-Myers Squibb extend partnership
Read More
OSI Pharmaceuticals presents new macrophage-stimulating protein receptor inhibitors
Read More
Pharmalink in-licenses Archimedes Pharma technology
Read More
Treatment begins in pivotal phase III CXA-201 trial
Read More
Avila Therapeutics product shows promise to treat hematological cancers
Read More
Bayer HealthCare submits applications for long-term contraceptive system
Read More
ATx08-001 study meets primary objectives
Read More
Zybrestat to be provided on a compassionate-use basis
Read More
Veregen mutual recognition approval process continues
Read More